Search research articles
Contact Us
Filters
Showing results (21-30 of 74) with videos related to
Page
of 8
Sort By:
Microbial Cell Factories
|
February 1, 2023
Barriers to simultaneous multilocus integration in Bacillus subtilis tumble down: development of a straightforward screening method for the colorimetric detection of one-step multiple gene insertion using the CRISPR-Cas9 system
Jordi Ferrando, Oriana Filluelo, Daniel R Zeigler, et al.
American Journal of Hematology
|
July 1, 1989
Successful treatment of severe refractory aplastic anemia with 3-beta etiocholanolone and nandrolone decanoate
T R Seewald, Z R Zeigler, F H Gardner
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 1, 1992
Potentiation of uremic bleeding by hereditary storage pool disease
R M Berty, Z R Zeigler, F J Bruns
Applied and Environmental Microbiology
|
August 23, 2015
Experimental evolution of enhanced growth by Bacillus subtilis at low atmospheric pressure: genomic changes revealed by whole-genome sequencing
Samantha M Waters, Daniel R Zeigler, Wayne L Nicholson
British Journal of Haematology
|
March 1, 1994
alpha-Interferon in myelofibrosis: a case report
K P Dalla, Z R Zeigler, R K Shadduck
Antonie Van Leeuwenhoek
|
November 14, 2019
Promotion of Bacillus subtilis subsp. inaquosorum, Bacillus subtilis subsp. spizizenii and Bacillus subtilis subsp. stercoris to species status
Christopher A Dunlap, Michael J Bowman, Daniel R Zeigler
British Journal of Haematology
|
January 1, 1993
Resolution of transfusion dependence by recombinant human erythropoietin (rHuEPO) in acquired pure red cell aplasia (PRCA) associated with myeloid metaplasia
Z R Zeigler, C S Rosenfeld, R K Shadduck
Bone Marrow Transplantation
|
April 30, 2002
Clearance of erythrocyte allo-antibodies using Rituximab
J Gryn, Z R Zeigler, R K Shadduck, et al.
Stem Cells (Dayton, Ohio)
|
January 1, 1993
Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome
Z R Zeigler, D Jones, C S Rosenfeld, et al.
AJNR. American Journal of Neuroradiology
|
February 19, 2004
Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation
Walter S Bartynski, Zella R Zeigler, Richard K Shadduck, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 74) with videos related to
Sort By:
Page
of 8
Microbial Cell Factories
|
February 1, 2023
Barriers to simultaneous multilocus integration in Bacillus subtilis tumble down: development of a straightforward screening method for the colorimetric detection of one-step multiple gene insertion using the CRISPR-Cas9 system
Jordi Ferrando, Oriana Filluelo, Daniel R Zeigler, et al.
American Journal of Hematology
|
July 1, 1989
Successful treatment of severe refractory aplastic anemia with 3-beta etiocholanolone and nandrolone decanoate
T R Seewald, Z R Zeigler, F H Gardner
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 1, 1992
Potentiation of uremic bleeding by hereditary storage pool disease
R M Berty, Z R Zeigler, F J Bruns
Applied and Environmental Microbiology
|
August 23, 2015
Experimental evolution of enhanced growth by Bacillus subtilis at low atmospheric pressure: genomic changes revealed by whole-genome sequencing
Samantha M Waters, Daniel R Zeigler, Wayne L Nicholson
British Journal of Haematology
|
March 1, 1994
alpha-Interferon in myelofibrosis: a case report
K P Dalla, Z R Zeigler, R K Shadduck
Antonie Van Leeuwenhoek
|
November 14, 2019
Promotion of Bacillus subtilis subsp. inaquosorum, Bacillus subtilis subsp. spizizenii and Bacillus subtilis subsp. stercoris to species status
Christopher A Dunlap, Michael J Bowman, Daniel R Zeigler
British Journal of Haematology
|
January 1, 1993
Resolution of transfusion dependence by recombinant human erythropoietin (rHuEPO) in acquired pure red cell aplasia (PRCA) associated with myeloid metaplasia
Z R Zeigler, C S Rosenfeld, R K Shadduck
Bone Marrow Transplantation
|
April 30, 2002
Clearance of erythrocyte allo-antibodies using Rituximab
J Gryn, Z R Zeigler, R K Shadduck, et al.
Stem Cells (Dayton, Ohio)
|
January 1, 1993
Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome
Z R Zeigler, D Jones, C S Rosenfeld, et al.
AJNR. American Journal of Neuroradiology
|
February 19, 2004
Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation
Walter S Bartynski, Zella R Zeigler, Richard K Shadduck, et al.
Page
of 8